Virtu Financial LLC United Therapeutics Corp Transaction History

Virtu Financial LLC

  • $1.31 Billion
  • Q1 2024

A detailed history of Virtu Financial LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Virtu Financial LLC holds 1,530 shares of UTHR stock, worth $487,381. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,530
Previous 6,155 75.14%
Holding current value
$487,381
Previous $1.35 Million 74.06%
% of portfolio
0.03%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024
SELL
$210.76 - $249.51 $974,765 - $1.15 Million
-4,625 Reduced 75.14%
1,530 $351,000
Q4 2023

Feb 26, 2024
BUY
$214.88 - $256.94 $1.32 Million - $1.58 Million
6,155 New
6,155 $1.35 Million
Q2 2021

Sep 17, 2021
SELL
$170.47 - $211.93 $440,494 - $547,627
-2,584 Closed
0 $0
Q1 2021

May 19, 2021
BUY
$153.94 - $174.85 $397,780 - $451,812
2,584 New
2,584 $432,000
Q4 2020

Feb 24, 2021
SELL
$101.87 - $151.79 $264,148 - $393,591
-2,593 Closed
0 $0
Q3 2020

Dec 11, 2020
BUY
$99.9 - $121.13 $259,040 - $314,090
2,593 New
2,593 $262,000
Q2 2020

Aug 07, 2020
SELL
$92.74 - $125.82 $533,255 - $723,465
-5,750 Closed
0 $0
Q4 2019

Feb 04, 2020
SELL
$78.31 - $95.34 $66,406 - $80,848
-848 Reduced 12.85%
5,750 $506,000
Q3 2019

Nov 20, 2019
BUY
$74.85 - $85.99 $285,927 - $328,481
3,820 Added 137.51%
6,598 $526,000
Q2 2019

Aug 13, 2019
SELL
$76.06 - $120.81 $142,308 - $226,035
-1,871 Reduced 40.25%
2,778 $217,000
Q1 2019

Apr 12, 2019
BUY
$107.15 - $126.84 $498,140 - $589,679
4,649 New
4,649 $546,000
Q4 2017

Feb 09, 2018
SELL
$118.58 - $151.28 $1.29 Million - $1.65 Million
-10,914 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$114.6 - $136.81 $1.25 Million - $1.49 Million
10,914
10,914 $1,000

Others Institutions Holding UTHR

# of Institutions
561
Shares Held
43.1M
Call Options Held
501K
Put Options Held
529K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email